IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies

por Parrondo, Ricardo D., Iqbal, Madiha, Von Roemeling, Reinhard, Von Roemeling, Christina, Tun, Han W.
Publicado 2023

What are barriers and facilitators in sustaining lean management in healthcare? A qualitative literature review

por Kunnen, Y. S., Roemeling, O. P., Smailhodzic, E.
Publicado 2023

Overdiagnosis and overtreatment of early detected prostate cancer

por Bangma, C. H., Roemeling, S., Schröder, F. H.
Publicado 2007

Outsourcing the Management of Reusable Medical Devices in a Chain-Wide Care Setting: Mixed Methods Feasibility Study

por Noort, Bart A C, Buijs, Paul, Roemeling, Oskar
Publicado 2023

Imidazole catalyzes chlorination by unreactive primary chloramines

por Roemeling, Margo D., Williams, Jared, Beckman, Joseph S., Hurst, James K.
Publicado 2015

How improving access times had unforeseen consequences: a case study in a Dutch hospital

por Roemeling, Oskar, Ahaus, Kees, van Zanten, Folkert, Land, Martin, Wennekes, Patrick
Publicado 2019

Cone beam computed tomography for detecting residual stones in percutaneous nephrolithotomy, a randomized controlled trial (CAPTURE) protocol

por Kingma, R. A., de Jong, I. J., Greuter, M. J. W., Roemeling, S.
Publicado 2021

Unveiling the Impact of Lean Leadership on Continuous Improvement Maturity: A Scoping Review

por Hilverda, Jesse Jorian, Roemeling, Oskar, Smailhodzic, Edin, Aij, Kjeld Harald, Hage, Eveline, Fakha, Amal
Publicado 2023

Tirapazamine-cisplatin: the synergy.

por Gatzemeier, U., Rodriguez, G., Treat, J., Miller, V., von Roemeling, R., Viallet, J., Rey, A.
Publicado 1998

Intraoperative cone beam computed tomography for detecting residual stones in percutaneous nephrolithotomy: a feasibility study

por Kingma, R. A., Voskamp, M. J. H., Doornweerd, B. H. J., de Jong, I. J., Roemeling, S.
Publicado 2021

P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA

por Von Roemeling, C., Iqbal, M., Doonan, B., Hoang-Minh, L., Klippel, K., Tun, H., Mitchell, D.
Publicado 2022

Involvement of MicroRNA-210 Demethylation in Steroid-associated Osteonecrosis of the Femoral Head

por Yuan, Heng-feng, Christina, Von Roemeling, Guo, Chang-an, Chu, Yi-wei, Liu, Rong-hua, Yan, Zuo-qin
Publicado 2016

Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors

por Guidetti, Francesca, Arribas, Alberto J., Sartori, Giulio, Spriano, Filippo, Barnabei, Laura, Tarantelli, Chiara, Von Roemeling, Reinhard, Martinez, Elizabeth, Zucca, Emanuele, Bertoni, Francesco
Publicado 2023

Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery

por Chen, Yuanxin, Liu, Xiujie, Yuan, Hengfeng, Yang, Zhaogang, von Roemeling, Christina A., Qie, Yaqing, Zhao, Hai, Wang, Yifan, Jiang, Wen, Kim, Betty Y. S.
Publicado 2019

VISTA expression and patient selection for immune-based anticancer therapy

por Martin, Alexander S., Molloy, Michael, Ugolkov, Andrey, von Roemeling, Reinhard W., Noelle, Randolph J., Lewis, Lionel D., Johnson, Melissa, Radvanyi, Laszlo, Martell, Robert E.
Publicado 2023

Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma

por Yushi, Qiu, Li, Zhimin, Von Roemeling, Christina A., Doeppler, Heike, Marlow, Laura A., Kim, Betty Y.S., Radisky, Derek C., Storz, Peter, Copland, John A., Tun, Han W.
Publicado 2016

Infusing Mesenchymal Stromal Cells into Porcine Kidneys during Normothermic Machine Perfusion: Intact MSCs Can Be Traced and Localised to Glomeruli

por Pool, Merel, Eertman, Tim, Sierra Parraga, Jesus, ’t Hart, Nils, Roemeling-van Rhijn, Marieke, Eijken, Marco, Jespersen, Bente, Reinders, Marlies, Hoogduijn, Martin, Ploeg, Rutger, Leuvenink, Henri, Moers, Cyril
Publicado 2019

Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma

por Tun, Han W., Marlow, Laura A., von Roemeling, Christina A., Cooper, Simon J., Kreinest, Pamela, Wu, Kevin, Luxon, Bruce A., Sinha, Mala, Anastasiadis, Panos Z., Copland, John A.
Publicado 2010

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

por Qie, Yaqing, Yuan, Hengfeng, von Roemeling, Christina A., Chen, Yuanxin, Liu, Xiujie, Shih, Kevin D., Knight, Joshua A., Tun, Han W., Wharen, Robert E., Jiang, Wen, Kim, Betty Y.S.
Publicado 2016

Corrigendum: Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

por Qie, Yaqing, Yuan, Hengfeng, von Roemeling, Christina A., Chen, Yuanxin, Liu, Xiujie, Shih, Kevin D., Knight, Joshua A., Tun, Han W., Wharen, Robert E., Jiang, Wen, Kim, Betty Y. S.
Publicado 2016